Loading insider details...
Beta
Latest Form 4 (Aug 11, 2026): Exercise/Conversion of 5,000 SYRE shares, $52.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 11, 2026 | Spyre Therapeutics, Inc. (SYRE) | Exercise/Conversion | 5,000 | $52.0K |
| Jun 25, 2026 | Kymera Therapeutics, Inc. (KYMR) | Grant/Award | 6,068 | n/a |
| May 29, 2026 | Spyre Therapeutics, Inc. (SYRE) | Grant/Award | 8,026 | n/a |
| Dec 8, 2025 | Kymera Therapeutics, Inc. (KYMR) | Exercise/Conversion | 5,000 | $70.9K |
| Oct 14, 2025 | Kymera Therapeutics, Inc. (KYMR) | Exercise/Conversion | 5,000 | $51.7K |
| Jun 27, 2025 | Kymera Therapeutics, Inc. (KYMR) | Grant/Award | 16,000 | n/a |
| Jun 3, 2025 | Kymera Therapeutics, Inc. (KYMR) | Exercise/Conversion | 6,349 | $65.6K |
| Jun 2, 2025 | Spyre Therapeutics, Inc. (SYRE) | Grant/Award | 25,000 | n/a |
| Nov 8, 2024 | Spyre Therapeutics, Inc. (SYRE) | Sale | 6,700 | $246.3K |
| Oct 28, 2024 | Spyre Therapeutics, Inc. (SYRE) | Sale | 300 | $10.9K |